Kamada Ltd.

Foreign Filer Report • Jun 15, 2016

_________ false

C002����� ��"�2PublicKAMADA LTD10215Corporation no: 511524605Stock Exchange/Market: -11934380Sapir 7 P.O.B 4081 , Ness-Ziona 74036 , ISRAEL ,Tel: 08-9406472 , Fax: 08-9406473E.mail address: liatc@kamada.comReported via MAGNA: 15/06/2016              Time of broadcast: 13:53 13:50:48

Company site:		www.kamada.com

Reference: 2016-02-050817

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on SHIRE AND KAMADA ANNOUNCE FDA APPROVAL OF EXPANDED LABEL FOR SELF-INFUSION OF GLASSIA FOR THE TREATMENT OF EMPHYSEMA DUE TO SEVERE AAT DEFICIENCY
15_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 08/06/2016
- - -
Name of the Signatory: : Livneh Nir , Position of Signatory in the reporting corporation: Attorney/Legal Counsel , Name of Employer Company: .
Sapir 7 Ness-Ziona 74036 Telephone: 072-2748242 , Facsimile: 072-2449318 , E-mail: nirl@kamada.com 1